Published in Infect Immun on April 25, 2011
Mechanisms of immune evasion in leishmaniasis. Adv Appl Microbiol (2013) 1.04
Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1. PLoS One (2012) 0.88
Differential effects of stimulatory factors on natural killer cell activities of young and aged mice. J Gerontol A Biol Sci Med Sci (2012) 0.82
Natural killer cells in experimental and human leishmaniasis. Front Cell Infect Microbiol (2012) 0.82
TNF-Mediated Restriction of Arginase 1 Expression in Myeloid Cells Triggers Type 2 NO Synthase Activity at the Site of Infection. Cell Rep (2016) 0.78
Evaluation of FcγRIIIB-NA1/NA2 Polymorphism in Visceral Leishmaniasis. Iran Red Crescent Med J (2014) 0.78
Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response. Front Microbiol (2016) 0.76
Memory T cells in cutaneous leishmaniasis. Cell Immunol (2016) 0.75
Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis. Inflamm Res (2011) 0.75
Redundant and regulatory roles for TLRs in Leishmania infection. Clin Exp Immunol (2017) 0.75
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91
Immune response in mice that lack the interferon-gamma receptor. Science (1993) 12.15
Nitric oxide and the immune response. Nat Immunol (2001) 10.00
Adaptive immune features of natural killer cells. Nature (2009) 8.46
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med (1993) 8.03
Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol (2008) 7.88
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med (1993) 4.49
Interleukin-10: new perspectives on an old cytokine. Immunol Rev (2008) 3.94
Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol (1990) 3.79
Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A (1995) 3.53
Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol (2005) 2.96
IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol (1995) 2.72
Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med (1999) 2.51
Molecular basis of the dual functions of 2B4 (CD244). J Immunol (2008) 2.50
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med (1996) 2.45
Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med (1994) 2.41
Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med (2006) 2.30
Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J Immunol (2002) 2.29
Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity (1998) 2.22
Keeping NK cells in highly regulated antiviral warfare. Trends Immunol (2007) 2.03
Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol (1998) 1.89
Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol (2007) 1.84
Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes. Eur J Immunol (1990) 1.74
Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med (2009) 1.70
Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity (2008) 1.65
Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Clin Infect Dis (2000) 1.63
The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol (2003) 1.60
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Early parasite containment is decisive for resistance to Leishmania major infection. Eur J Immunol (1995) 1.55
Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect Immun (1991) 1.48
TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol (2007) 1.46
Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science (1999) 1.46
Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN-gamma in IL-12/IL-18-stimulated mouse macrophage populations. Blood (2004) 1.44
Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J Immunol (1986) 1.43
Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol (2001) 1.42
Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol (2005) 1.39
Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur J Immunol (1993) 1.34
Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection. J Immunol (2009) 1.32
NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood (2009) 1.29
IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J Immunol (2009) 1.27
Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int Immunol (2002) 1.23
Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol (1998) 1.20
NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol (2004) 1.20
Mistaken notions about natural killer cells. Nat Immunol (2008) 1.19
Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J Immunol (2010) 1.17
Modulation of natural killer cell activity by viruses. Curr Opin Microbiol (2010) 1.16
Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin. Clin Exp Immunol (1991) 1.12
Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infect Immun (2007) 1.09
Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J Immunol (1997) 1.08
Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi. Infect Immun (2010) 1.06
Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J Exp Med (2010) 1.05
Leishmania major-specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophages. Eur J Immunol (1994) 1.04
Participation of natural killer cells in the recovery of mice from visceral leishmaniasis. Cell Immunol (1985) 1.04
Generation, culture and flow-cytometric characterization of primary mouse macrophages. Methods Mol Biol (2009) 1.00
Immature human dendritic cells infected with Leishmania infantum are resistant to NK-mediated cytolysis but are efficiently recognized by NKT cells. J Immunol (2006) 0.97
Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity. Infect Immun (2009) 0.96
Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection. Infect Immun (2008) 0.95
VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog (2008) 0.94
Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitro. Cell Immunol (1988) 0.93
Gr-1high polymorphonuclear leukocytes and NK cells act via IL-15 to clear intracellular Haemophilus influenzae in experimental murine peritonitis and pneumonia. J Immunol (2007) 0.87
A homogeneous population of lymphokine-activated killer (LAK) cells is incapable of killing virus-, bacteria-, or parasite-infected macrophages. Cell Immunol (1990) 0.87
Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection. Scand J Immunol (2005) 0.86
IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo. Eur J Immunol (2010) 0.85
Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo. J Immunol (2007) 0.81
The cytolytic activity of natural killer cells is not involved in the restriction of Mycobacterium avium growth. Int Immunol (2003) 0.81
Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell. Vaccine (2009) 0.80
Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells. J Leukoc Biol (2010) 0.80
Perforin enhances the granulysin-induced lysis of Listeria innocua in human dendritic cells. BMC Immunol (2007) 0.80
The role of natural killer cells in the early period of infection in murine cutaneous leishmaniasis. Braz J Med Biol Res (1999) 0.80
Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major. Immunology (2010) 0.77
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol (2008) 4.31
Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med (2006) 3.12
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol (2003) 2.44
Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med (2002) 2.37
Detection of "Candidatus Neoehrlichia mikurensis" in two patients with severe febrile illnesses: evidence for a European sequence variant. J Clin Microbiol (2010) 1.82
Hydrolytic reactivity trends among potential prodrugs of the O2-glycosylated diazeniumdiolate family. Targeting nitric oxide to macrophages for antileishmanial activity. J Med Chem (2008) 1.62
Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog (2008) 1.58
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Production of interferon-gamma by myeloid cells--fact or fancy? Trends Immunol (2006) 1.55
Translational control of inducible nitric oxide synthase by IL-13 and arginine availability in inflammatory macrophages. J Immunol (2003) 1.54
The role of type I interferons in non-viral infections. Immunol Rev (2004) 1.50
Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation. Nephrol Dial Transplant (2010) 1.49
TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol (2007) 1.46
Minute numbers of contaminant CD8+ T cells or CD11b+CD11c+ NK cells are the source of IFN-gamma in IL-12/IL-18-stimulated mouse macrophage populations. Blood (2004) 1.44
High diversity of ankA sequences of Anaplasma phagocytophilum among Ixodes ricinus ticks in Germany. J Clin Microbiol (2003) 1.41
The innate immune response against Leishmania parasites. Immunobiology (2008) 1.39
High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol (2011) 1.26
Tuboovarian abscess caused by Atopobium vaginae following transvaginal oocyte recovery. J Clin Microbiol (2003) 1.25
Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med (2013) 1.22
Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur J Immunol (2003) 1.22
Generation of transgenic cattle by lentiviral gene transfer into oocytes. Biol Reprod (2004) 1.21
Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J Immunol (2006) 1.18
Protection against progressive leishmaniasis by IFN-beta. J Immunol (2004) 1.12
Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infect Immun (2007) 1.09
Expression of inducible nitric oxide synthase in skin lesions of patients with american cutaneous leishmaniasis. Infect Immun (2002) 1.08
The IFN-γ-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens. PLoS One (2011) 1.06
The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling. PLoS One (2013) 1.02
Generation, culture and flow-cytometric characterization of primary mouse macrophages. Methods Mol Biol (2009) 1.00
Small interfering RNA (siRNA) delivery into murine bone marrow-derived macrophages by electroporation. J Immunol Methods (2009) 0.98
The role of epithelial Toll-like receptor expression in host defense and microbial tolerance. J Endotoxin Res (2005) 0.96
The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Microbes Infect (2004) 0.96
Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1α (HIF1A) and result in differential HIF1A-dependent gene expression. J Leukoc Biol (2011) 0.93
The elimination of Anaplasma phagocytophilum requires CD4+ T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms. Eur J Immunol (2008) 0.92
Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury. Clin Vaccine Immunol (2006) 0.92
Striking inflammation from both sides: manganese(II) pentaazamacrocyclic SOD mimics act also as nitric oxide dismutases: a single-cell study. Angew Chem Int Ed Engl (2010) 0.91
NKT cells mediate organ-specific resistance against Leishmania major infection. Microbes Infect (2005) 0.90
Impairment of gamma interferon signaling in human neutrophils infected with Anaplasma phagocytophilum. Infect Immun (2009) 0.89
Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta. Am J Pathol (2008) 0.87
Innate immune tissue injury and murine HGA: tissue injury in the murine model of granulocytic anaplasmosis relates to host innate immune response and not pathogen load. Ann N Y Acad Sci (2005) 0.86
Oxidative burst without phagocytes: the role of respiratory proteins. Nat Immunol (2007) 0.86
Renal leishmaniasis as unusual cause of nephrotic syndrome in an HIV patient. J Am Soc Nephrol (2012) 0.86
Protective immunity and delayed type hypersensitivity reaction are uncoupled in experimental Leishmania major infection of CCR6-negative mice. Microbes Infect (2006) 0.86
The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. J Clin Invest (2016) 0.86
IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo. Eur J Immunol (2010) 0.85
Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections. Int Immunol (2007) 0.85
Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages. Infect Immun (2012) 0.84
TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Microbes Infect (2005) 0.83
Penetration of cercariae into the living human skin: Schistosoma mansoni vs. Trichobilharzia szidati. Parasitol Res (2009) 0.83
First assessment for the presence of phlebotomine vectors in Bavaria, Southern Germany, by combined distribution modeling and field surveys. PLoS One (2013) 0.83
Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response. PLoS Negl Trop Dis (2012) 0.83
Control of Leishmania major in the absence of Tyk2 kinase. Eur J Immunol (2004) 0.82
Immunogenicity and diagnostic potential of synthetic antigenic cell surface glycans of Leishmania. ACS Chem Biol (2013) 0.81
Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany. J Antimicrob Chemother (2007) 0.81
Protection against RNA-induced liver damage by myeloid cells requires type I interferon and IL-1 receptor antagonist in mice. Hepatology (2014) 0.80
Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis. Immunobiology (2010) 0.80
Schistosoma mansoni: human skin ceramides are a chemical cue for host recognition of cercariae. Exp Parasitol (2008) 0.80
Toll-like receptor ligation for the induction of regulatory B cells. Methods Mol Biol (2014) 0.80
[Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany]. J Dtsch Dermatol Ges (2011) 0.78
Cytokine-mediated control of lipopolysaccharide-induced activation of small intestinal epithelial cells. Immunology (2007) 0.78
Translational repression of inducible NO synthase in macrophages by l-arginine depletion is not associated with an increased phosphorylation of eIF2alpha. Immunobiology (2009) 0.77
Human granulocytic ehrlichiosis in Germany: evidence from serological studies, tick analyses, and a case of equine ehrlichiosis. Ann N Y Acad Sci (2003) 0.77
Analysis of the antimicrobial activity of local anaesthetics used for dental analgesia. J Med Microbiol (2008) 0.76
Severe soft tissue infection caused by a non-beta-hemolytic Streptococcus pyogenes strain harboring a premature stop mutation in the sagC gene. J Clin Microbiol (2013) 0.75
A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan. BMC Infect Dis (2014) 0.75
Comment on "TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions". J Immunol (2009) 0.75
Correspondence (letter to the editor): Targeted second-line treatment. Dtsch Arztebl Int (2010) 0.75
ASMase: the tailor of cytotoxic T cell granule exocytosis. Nat Immunol (2009) 0.75
[Diagnosis and therapy of cutaneous and musculocutaneous Leishmaniasis in Germany]. J Dtsch Dermatol Ges (2009) 0.75
Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers. Eur J Dermatol (2013) 0.75
Electroporation of siRNA into mouse bone marrow-derived macrophages and dendritic cells. Methods Mol Biol (2014) 0.75
Corrigendum: IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma. Sci Rep (2017) 0.75
Obituary. Nitric Oxide (2014) 0.75
Two cases of successful treatment of multilesional cutaneous leishmaniasis with liposomal amphotericin B. J Dtsch Dermatol Ges (2012) 0.75
Macrophage and dendritic cells. Editorial. Immunobiology (2007) 0.75
Mechanisms of immunological control of Anaplasma phagocytophilum in mice. Ann N Y Acad Sci (2005) 0.75